Pharma Journalist -

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been…
Read More...

Thermo Fisher Scientific Inc., the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to…
Read More...

Cybeats Technologies Corp. is pleased to announce the commencement of a trial evaluation with one of the top-3 largest software companies by total revenue, for Cybeats SBOM Studio.…
Read More...

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene…
Read More...

Curia announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced the primary and all key secondary endpoints were met in a Phase 3 trial evaluating the investigational use of Dupixent (dupilumab)…
Read More...

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been conditionally approved in China for the treatment of adult…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a worldwide drug discovery collaboration agreement with Macomics Ltd, a leader in macrophage drug discovery, to develop…
Read More...

Moderna, Inc. and Generation Bio Co. announced that the two companies have entered into a strategic collaboration to combine Moderna’s biological and technical expertise with core…
Read More...

The good news continues as BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of…
Read More...